Imminent approval of the Pfizer Covid-19 vaccine in adolescence is expected to boost a deadlocked immunization campaign in the United States while helping more schools return to face-to-face learning.
However, it also sparked debate about the ethical considerations of vaccination of low-risk populations, while pandemics intensified in other countries, such as India, where high-risk groups continue to be vaccinated. ..
In March, Pfizer and its partner BioNTech said a study of about 2,300 people aged 12 to 15 years showed that a double-dose regimen was safe and highly effective.
If an Emergency Use Authorization (EUA) is granted (as widely expected by next week), President Joe Biden will promptly vaccinate as many adolescents as possible by the time the school reopens in the fall. I called to.
Approximately 148 million of the 330 million people in the country receive one or more doses. This is about 44 percent of the population.
However, that percentage peaked around April 10 and has declined since then, with vaccine endurance slowing competition for herd immunity.
Former FDA Commissioner Scott Gottlieb told CBS News on Sunday that he had about 17 million children between the ages of 12 and 15 and predicted that interest from enthusiastic families would soon increase.
However, many experts have expressed concern about whether it is the right time to vaccinate teens in the United States now that the global situation is deteriorating.
The issue of vaccine inequity was clearly focused by India, which reported 350,000 new cases on Tuesday and recorded nearly 3,500 deaths, more than anywhere else in the world.
“We know that the overwhelming majority of 15-year-olds are not at high risk of serious complications from COVID,” said Craig Spencer, MD, Global Health Director of Emergency Medicine, Columbia University, AFP. Told to.
“It’s absolutely rampant around the world. The overwhelming majority of healthcare professionals around the world are discussing how to vaccinate incredibly low-risk people when they are unprotected.” He said.
Priya Sampathkumar, chair of infection prevention and control at the Mayo Clinic, Minnesota, added that not only is it an ethical issue, but it is in the United States’ own interest to export more vaccines.
“If more variants of India, Nepal and South Asia get out of control and hit our shore, vaccination of more people in the United States will not help us,” she told AFP. Told.
“It is short-sighted to continue vaccination of people here and not to send vaccines to areas of greatest need.”
The United States has promised to release up to 60 million doses of AstraZeneca vaccine, but Spencer, Sampath Kumar and others believe they can do much more.
Sampath Kumar added that the main reason for vaccination of teens is to reduce infections. This is a goal she agreed to, but it’s a timing issue as US cases are declining.
“Most children actually recover quickly. The reason they actually get vaccinated is for adults, grandparents, and immunosuppressed people who have vaccinated themselves but have poor immune responses. To protect, “she explained.
Statistics show that children are generally at very low risk of severe Covid.
According to the latest official data, there are a total of 277 deaths under the age of 18 in the United States, a small percentage of the total 574,000.
A rare but serious post-viral disease, pediatric multisystem inflammatory syndrome (MIS-C), has killed an additional 36 people.
Still, low risk is not risk-free, and pediatrician Lee Beers, chairman of the American Academy of Pediatrics, welcomed the arrival of vaccines for children.
“This is a big step forward in protecting children and allowing them to do everything they love safely without worrying about it,” she told AFP.
Beer calls vaccination “an important tool in the toolbox for returning to school safely,” and states that it “may increase the comfort of many families and school staff.”
According to data compiled on Burbio’s site, 67.1% of U.S. school students go directly to school, while 29.6% are in a “hybrid” setting that combines face-to-face and remote classes, and 3.3% are facts. I’m learning above.
More companies, including Moderna, Johnson & Johnson, and Novavax, will soon apply for Covid vaccine approval.
As Pandemic Rages Globally, US Set To Vaccinate Low-risk Teens Source link As Pandemic Rages Globally, US Set To Vaccinate Low-risk Teens